跳至主要内容
临床试验/NCT06889181
NCT06889181尚未招募不适用

Evaluation of the Role of the Plasma-rich Growth Factor (PRGF) with Primary Cleft Palate Repair Versus Primary Cleft Palate Repair in Post-operative Wound Healing and Oronasal Fistula Occurrence, a Randomized Clinical Trial

Cairo University1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2025年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
36
试验地点
1
主要终点
wound healing assesment (edema at 5th day post operatively)

研究概览

简要总结

Does the plasma-rich growth factor (PRGF) with primary cleft palate repair accelerate wound healing and prevent post-operative oronasal fistula occurrence?

详细描述

The primary objective is to assess and evaluate the improvement of wound healing (edema at 5th day post operatively) as a primary outcome, and secondary objective is to assess and evaluate the wound closure and the decreasing of the occurrence of the oronasal fistula as a secondary outcome among children with cleft palate, using plasma rich growth factor between nasal mucosa and palatal mucosa

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

盲法说明

Single blinded study. Blinding to the patient will be ensured by masking the instruments during the follow up. The patient will be informed of the steps of the follow up (as mentioned in the consent form) without getting into details of the method of follow up.

入排标准

年龄范围
6 Months 至 18 Months(Child)
性别
All
接受健康志愿者
是

入选标准

  • •systemically healthy patients (American Society of Anesthesiologists -ASA I and II); not older than 6-18 months
  • •Patients with primary non-syndromic isolated cleft palate
  • •Apprehensive to be in the study.

排除标准

  • •Patients with recurrent palatal fistula
  • •Existence of syndromic cleft palate
  • •Blood diseases and platelet disorders (hematological disease)
  • •Systematic disease radiotherapy or chemotherapy for malignancy

研究组 & 干预措施

plasma rich growth factor (PRGF) (intervention or study group)

Active Comparator

plasma rich growth factor (PRGF) intervention or study group Has Surgical procedures "von Langenbeck technique " to repair cleft palate and placing plasma rich growth factors between nasal and palatal tissue then primary closure intraoperatively, then patient will come for follow up visit after surgery, 1st day, 3rd, 5th day and come for follow up visits at 1 week, 1 month and 3 months postoperative

干预措施: Plasma Rich in Growth Factors (PRGF) (Other)

placebo (control group)

Placebo Comparator

placebo (control group) Has Surgical procedures "von Langenbeck technique " to repair cleft palate primary closure, then patient will come for follow up visit after surgery, 1st day, 3rd, 5th day and come for follow up visits at 1 week, 1 month and 3 months postoperative

干预措施: Placebo (Other)

结局指标

主要结局

wound healing assesment (edema at 5th day post operatively)

时间窗: first day after surgery, 3rd day, and 5th day

clinical records, percentage of persistence of edema number of participants with percentage of persisting of edema

次要结局

  • wound healing assesment(2 years)
  • the occurrence of oronasal fistula(first day after surgery to end of treatment at 3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sarah Samir Horia

assistant lecturer

Cairo University

研究点 (1)

Loading locations...

相似试验